The VP of Clinical Development will oversee implementation and maintenance of all metabolic internal clinical development programs and will also have the strategic view and excellence in execution to continue to grow the strength and scope of the internal pipeline, in addition to participating in potential business development opportunities, including additional acquisitions. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.